Malignant hyperthermia (MH) is a pharmacogenetic disorder of skeletal muscle that manifests in response to anesthetic triggering agents. Central core disease (CCD) is a myopathy closely associated with MH. Both MH and CCD are primarily disorders of calcium regulation in skeletal muscle. The ryanodin
Novel mutations at a CpG dinucleotide in the ryanodine receptor in malignant hyperthermia
β Scribed by Bernadette M. Manning; Kathleen A. Quane; Patrick J. Lynch; Albert Urwyler; Vincenzo Tegazzin; Renee Krivosic-Horber; Kathrin Censier; Giacomo Comi; Pascal Adnet; Werner Wolz; Joel Lunardi; Clemens R. Muller; Tommie V. McCarthy
- Publisher
- John Wiley and Sons
- Year
- 1998
- Tongue
- English
- Weight
- 168 KB
- Volume
- 11
- Category
- Article
- ISSN
- 1059-7794
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
of CpG dinucleotides within the HPRT gene and the fre-Studies of human genetic disorders have suggested that quency of mutations at these sites. 5-methylcytosine moieties in DNA may act as endoge-Germ cell mutations in the X-chromosome HPRT gene nous mutagens due to the increased deamination of C cl
Hypochondroplasia and achondroplasia are skeletal dysplasias, characterised by autosomal dominant inheritance and disproportionate short stature, which occurs mainly due to growth failure of the extremities. Both dysplasias have been mapped to fibroblast growth factor receptor 3 (FGFR3) gene. For hy